Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
• inVentiv Health (Burlington, MA) announced that Tom Sebok will be leading the company's advertising segment as the new President of inVentiv Health Communications. Mark Archer has also joined the company as Senior Vice President of European Operations and Development for inVentiv Health Commercial, which provides sales, marketing, communications, and patient outcome services to a wide variety of pharmaceutical, biotechnology, medical device, and life sciences companies.
Mark Archer
• Synteract (San Diego, CA) has hired Matthew P. Smith as Senior Vice President of Sales and Marketing and has promoted Rod M. Saponjic, PhD, to Senior Vice President, Global Project Management, to support growth in the company and development of international opportunities. Both executives join CEO Wendel Barr, COO Stewart Bieler, and CFO Patrik Jeanmonod on the executive council for the company.
Matthew P. Smith
• Quintiles (Research Triangle Park, NC) has appointd a new Chief Executive Officer, Tom Pike. Dennis Gillings, who founded the company, continues as Executive Chairman of its Board of Directors.
Tom Pike
• Theorem Clinical Research (King of Prussia, PA) has appointed Evan Rosenfeld, MD, as Vice President of Medical and Scientific Affairs, Medical Device and Diagnostics. Nitin Jain has also joined the company as Vice President and General Manager for the Asia-Pacific region in the Singapore office.
Evan Rosenfeld, MD
• Pharm-Olam International (Houston, TX) has welcomed John Barker as Executive Vice President, Corporate Operations. Within this post, Barker will be responsible for maintaining high-quality deliverables from POI's range of global trial services, including government contracts, data management, biostatistics, and other functional services.
• Premier Research Group (Philadelphia, PA) announced the appointment of Eeva-Kaarina Koskelo, PhD, to the position of Executive Director, Clinical Development Services, Pediatrics. In this position, Koskelo will play a principal role in the strategic planning and execution of pediatric studies at Premier Research.
• Chiltern International (London, UK) has hired Krista Stephenson to its global resourcing solutions team. Stephenson brings her expertise in the area of functional service provider and staffing models to serve clients' needs.
• Novella Clinical Resourcing (Research Triangle Park, NC), a division of Novella Clinical, has hired Colleen Dureau-Inzerillo as Global Head of Business Development.
• Bringing with her 18 years of clinical and regulatory drug development expertise in biopharmaceutical and clinical research industries, CTI Clinical Trial and Consulting Services (CTI) (Cincinnati, OH) has appointed Melanie A. Bruno, PhD, as Vice President, Clinical Trial Operations. CTI has made several other promotions and appointments including the promotion of Lynda Spiker to Assistant Director, Global Safety and Pharmacovigilance and Jessica Ashcraft's promotion to Accounting Clerk II. Three more additions, Teresa Rodriguez as Senior Clinical Research Associate at CTI, Spain, José-Luis Cascales as Clinical Project Manager Europe at CTI Europe, and Roberto Campos, JD, as Corporate Counsel, have recently joined the team.
• BioClinica (Newtown, PA) announced that Amarin Corporation has chosen the eClinical suite from BioClinica to capture and manage clinical data for their Phase IIIb cardiology clinical trial, including: electronic data capture and data management, interactive response technology, and clinical trial management solutions.
• Celerion (Lincoln, NE) and Ricerca Biosciences (Concord, OH) announced the formation of "The Biosimilars Alliance." The Biosimilars Alliance is focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.
• ICON (Dublin, Ireland) announced that it has been selected by Roche as its technology partner for storing and managing medical images collected during the company's clinical research programs.
• Copernicus Group IRB (Research Triangle Park, NC) has accepted Training Magazine's annual Training Top 125 award, which highlights companies' excellence in employer-sponsored training and development programs.
• clinicalRSVP.com (Fort Lauderdale, FL) announced that all seven sites making up the original clinicalRSVP user network, including Clinical Pharmacology of Miami (one site), Comprehensive Clinical Development (three sites), Elite Research Institute (one site), and Seaview Research Inc. (two sites), have agreed to extend their commitment to the clinicalRSVP network through 2012 and beyond.
• RadSite (Annapolis, MD) has enhanced its mission by recently expanding its on-site audit program designed to assess how imaging personnel are implementing their quality practices and maintaining their imaging equipment.
• Quintiles (Research Triangle Park, NC) marks the 30th Anniversary of the company's incorporation, transforming from a small statistical consulting firm housed in a university campus trailer to one of the world's largest biopharmaceutical services company with 25,000 employees and offices in 60-plus countries.
• Clinical Reference Laboratory (Lenexa, KS) has announced the full integration of its long-standing laboratory partner Phoenix Pharma Central Services in Singapore.
• The Association for the Accreditation of Human Research Protection Programs (Washington, DC) has accredited two more organizations: Boise VA Medical Center in Boise, ID, and VA Puget Sound Health Care System in Seattle, WA.
• In an effort to educate the public, media and policymakers about clinical trials and the growing role of clinical research organizations in the drug development process, the Association of Clinical Research Organizations (Washington, DC) has launched a YouTube channel @ACROHealthChannel.
• The International Academy of Clinical Research (Maidenhead, UK) has launched a campaign calling for the introduction of accredited clinical research training with a recognized industry standard and demonstrable, measurable levels of competence.
• ICON (Dublin, Ireland) announced the acquisition of PriceSpective. The acquisition strengthens ICON's exertise in value based pricing and market access.
• inVentiv Health (Burlington, MA) announced that it has signed a definitive agreement to acquire Kforce Clinical Research from Kforce Inc. for $50 million in cash.
• Quanticate (London, UK) announced expansion of its capabilities in India with the opening of a new office in Bangalore, India.
• Marken (Paris, France) continues their expansion of services in India, by augmenting their existing Mumbai facility with four additional branches to support the growing demand in clinical trial logistics within India. The expansion in New Delhi, Hydrabad, Pune, and Bangalore will support the growing need for temperature controlled logistics of sensitive drugs and cold chain specimens.
• CRF Health's (Plymouth Meeting, PA) new web-based tool, TrialMax Web™, offers a solution with patient usability benefits including enhanced patient focus to promote better engagement, data capture, and compliance to generate higher-quality data.
• Copernicus Group IRB (Research Triangle Park, NC) has released CGIRB Connexus® 2.0., an award-winning eDocument management system, utilized by sponsors, CROs, and sites to manage the IRB review process.
• The new Pharmatching.com (Freiburg, Germany)launched its "Google for Pharma & Biotech," a Web2.0 tool for finding the right partners in the pharmaceutical industry worldwide.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.